Clinical trial Recruiting at 2 sites Observational Ages 40 and up

10-year follow-up of adults screened for heart risk to create a Morocco-specific heart risk score

Official title: Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score

Run by Moroccan Society of Cardiology · NCT07294937 · Data updated 2026-11-12

This project will try to see if information from people screened 10 years ago can be used to build a heart disease risk score tailored for Moroccan adults age 40 and older.

More Cardiovascular Diseases (CVD) trials

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment10000 (estimated)
SponsorMoroccan Society of Cardiology
Academic / other
Locations2 sites (Casablanca and 1 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMarch 2026
Study endsOctober 2026
Registry record updatedDecember 19, 2025
Trial IDNCT07294937 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Moroccan adults who took part in the "All with heart" screening in Greater Casablanca between 2010 and 2012 and can provide written consent and be reached by phone, WhatsApp, or SMS.

Probably not a fit

People who cannot be reached, who moved away, who died from non-cardiovascular causes, or non-Moroccan participants are unlikely to benefit from this follow-up effort.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will re-contact more than 10,000 adults who participated in a 2010–2012 cardiovascular screening in Greater Casablanca to document cardiovascular deaths, heart attacks, and strokes using phone calls, WhatsApp, or SMS. Follow-up outcomes will be combined with baseline screening data to perform survival analysis and multivariable logistic regression. The team will use those results to develop and internally validate a predictive risk model specific to the Moroccan population. The project is coordinated by the Moroccan Society of Cardiology with clinical sites in Casablanca and Rabat and requires written informed consent for participation.

Why it matters

Potential benefit: If successful, the resulting Morocco-specific risk score could give clinicians a more accurate way to identify people at high risk of heart attack or stroke and target prevention locally.

How similar studies have gone: Long-term cohort studies and regional risk scores (for example Framingham or SCORE adaptations) have successfully predicted cardiovascular risk elsewhere, but a Morocco-specific model is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 40 years or older at the time of the initial screening (2010-2012).
* Individuals who participated in the cardiovascular risk screening campaign conducted by the "All with heart" Association between 2010 and 2012 in the Greater Casablanca region.
* Moroccan nationality.
* Participants or family members who provide written informed consent for participation in the 10-year follow-up study.

Exclusion Criteria:

* Individuals who refuse to participate in the follow-up study.
* Participants who have moved and cannot be reached by phone, WhatsApp, or SMS.
* Participants who died from non-cardiovascular causes.
* Non-Moroccan participants.

Where it's running

  • Moroccan Society of Cardiology
    Casablanca, Morocco
    Recruiting
  • Cardiology Centre, Mohammed V Military Hospital, Rabat, Morocco
    Rabat, Morocco
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.